title: [Diagnosis and treatment of osteoporosis in nonmetastatic breast cancer].
abstract: The prevention of cancer-treatment-induced bone loss due to chemotherapy and long-term adjuvant breast cancer therapy has a high priority. We present an algorithm for the prevention and treatment of osteoporosis during treatment of nonmetastatic breast cancer.
authors.affiliation: Kardiologisk-endokrinologisk Afdeling H, Hillerød Sygehus, 3400 Hillerød, Denmark. piei@hih.regionh.dk
authors.forename: Pia A
authors.initials: PA
authors.lastname: Eiken
authors.forename: Mogens
authors.initials: M
authors.lastname: Hansen
authors.forename: Bent
authors.initials: B
authors.lastname: Kristensen
authors.forename: Bente L
authors.initials: BL
authors.lastname: Langdahl
authors.forename: Bo
authors.initials: B
authors.lastname: Abrahamsen
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D058866:Osteoporotic Fractures / Q000139:chemically induced / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D012307:Risk Factors
chemical_list: D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D005938:Glucocorticoids; D011239:Prednisolone